Market Resilience: Reviva Pharmaceuticals Holdings Inc. (RVPH) Finishes Strong/Weak at 1.701, Down -9.09

Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Reviva Pharmaceuticals Holdings Inc. (NASDAQ: RVPH) closed the day trading at $1.70 down -9.09% from the previous closing price of $1.87. In other words, the price has decreased by -$9.09 from its previous closing price. On the day, 0.52 million shares were traded. RVPH stock price reached its highest trading level at $1.99 during the session, while it also had its lowest trading level at $1.68.

Ratios:

For a better understanding of RVPH, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.38 and its Current Ratio is at 1.38. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, ROTH MKM on September 20, 2023, initiated with a Buy rating and assigned the stock a target price of $12.

On June 08, 2023, The Benchmark Company started tracking the stock assigning a Speculative Buy rating and target price of $17.

On January 24, 2022, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $10.H.C. Wainwright initiated its Buy rating on January 24, 2022, with a $10 target price.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RVPH now has a Market Capitalization of 47461620 and an Enterprise Value of 24094096.

Stock Price History:

The Beta on a monthly basis for RVPH is -0.03, which has changed by -0.7803618 over the last 52 weeks, in comparison to a change of 0.2704494 over the same period for the S&P500. Over the past 52 weeks, RVPH has reached a high of $8.61, while it has fallen to a 52-week low of $1.82. The 50-Day Moving Average of the stock is -47.72%, while the 200-Day Moving Average is calculated to be -59.01%.

Shares Statistics:

Over the past 3-months, RVPH traded about 277.24K shares per day on average, while over the past 10 days, RVPH traded about 348460 shares per day. A total of 27.92M shares are outstanding, with a floating share count of 22.97M. Insiders hold about 17.71% of the company’s shares, while institutions hold 18.41% stake in the company. Shares short for RVPH as of 1714435200 were 1249916 with a Short Ratio of 4.51, compared to 1711584000 on 1058045. Therefore, it implies a Short% of Shares Outstanding of 1249916 and a Short% of Float of 6.710000000000001.

Earnings Estimates

The firm’s stock currently is rated by 3.0 analysts. On average, analysts expect EPS of -$0.38 for the current quarter, with a high estimate of -$0.28 and a low estimate of -$0.46, while EPS last year was -$0.3. The consensus estimate for the next quarter is -$0.36, with high estimates of -$0.22 and low estimates of -$0.48.

Analysts are recommending an EPS of between -$0.82 and -$1.87 for the fiscal current year, implying an average EPS of -$1.29. EPS for the following year is -$1.31, with 4.0 analysts recommending between -$0.76 and -$2.11.

Most Popular